Mon, Dec 22, 2014, 12:18 AM EST - U.S. Markets open in 9 hrs 12 mins


% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

  • ahtawil ahtawil Dec 23, 1997 9:31 PM Flag

    bsx in trouble, $25 to $30

    with avei's approval, market shares are evaporating fast !! bsx will be going down to $25 to $30

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Perhaps the share price of BSX will drop, but not because of AVE. BSX does not have a stent approved in the US yet, so there is no "market share" to evaporate in this regard. And AVE does not sell stand alone balloons in the US. As a stretch, it does not appear that AVE stents need a "post dilatation" balloon, so BSX may lose some of that market (as will any other "high pressure" balloon makers that sell into the post-dilatation market).

      GDT stent and balloon systems have seen a huge uptake in the last several months. I would imagine BSX is losing some balloon market to this situation. And Cordis' Charger has come onstream to great reviews.

      Until BSX has a stent approved in the US (PMA is supposed to be submitted right around now, then add 6 months to that as an estimate, although AVE only took 140 days, and GDT even less), then it won't lose stent market share in the US.

13.15-0.11(-0.83%)Dec 19 4:03 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.